LPS is able to augment TNF-α production and activate the toll-like receptor 4 (TLR-4) pathway, thereby inducing a hepatic inflammatory response, leading to the progression of liver fibrosis and HCC (87, 88). The gene discussed is TLR4; the disease is Hepatic fibrosis.